| 1 | 168835-82-3 | SU 1498 | SU 1498 | C25H30N2O2
| | |
| 2 | 6339-73-7 | NSC43907 | NSC43907 | C25H30N2O2
| | |
| 3 | 341549-58-4 | TRTNH-PEG3-NH2 | TRTNH-PEG3-NH2 | C25H30N2O2
| | |
| 4 | 605696-10-4 | 索利那新杂质14 | Solifenacin Related Compound 14 | C25H30N2O2
| 杂质对照品;对照品-杂质对照品 | |
| 5 | 189341-61-5 | MONO-TRITYL 1,4-DIAMINOBUTANE ACETIC ACID SALT | MONO-TRITYL 1,4-DIAMINOBUTANE ACETIC ACID SALT | C25H30N2O2
| | |
| 6 | | 1,3-Di(4-tert-butylbenzoyl)-2,3-dihydro-1H-imidazole | 1,3-Di(4-tert-butylbenzoyl)-2,3-dihydro-1H-imidazole | C25H30N2O2
| | |
| 7 | | N-(4-methoxyphenyl)-N'-[(2-phenyl-2-adamantyl)methyl]urea | N-(4-methoxyphenyl)-N'-[(2-phenyl-2-adamantyl)methyl]urea | C25H30N2O2
| | |
| 8 | 438613-59-3 | 2-(4-ethoxyphenyl)-N-(1-methylhexyl)-4-quinolinecarboxamide | 2-(4-ethoxyphenyl)-N-(1-methylhexyl)-4-quinolinecarboxamide | C25H30N2O2
| | |
| 9 | 2447575-76-8 | (4R,4'R)-2,2'-(庚烷-4,4-二基)双(4-苯基-4,5-二氢恶唑) | (4R,4'R)-2,2'-(Heptane-4,4-diyl)bis(4-phenyl-4,5-dihydrooxazole) | C25H30N2O2
| | |
| 10 | 160191-64-0 | (4S,4'S)-2,2'-(戊烷-3,3'-二基)双(4-苄基-4,5-二氢恶唑) | (4S,4'S)-2,2'-(Pentane-3,3'-diyl)bis(4-benzyl-4,5-dihydrooxazole) | C25H30N2O2
| | |
| 11 | 825607-12-3 | 1-[4-(2,3-dimethylphenyl)-1-piperazinyl]-3-(2-naphthyloxy)-2-propanol | 1-[4-(2,3-dimethylphenyl)-1-piperazinyl]-3-(2-naphthyloxy)-2-propanol | C25H30N2O2
| | |
| 12 | 1489257-33-1 | (4S,4'S)-2,2'-(庚烷-4,4-二基)双(4-苯基-4,5-二氢恶唑) | Oxazole, 2,2'-(1-propylbutylidene)bis[4,5-dihydro-4-phenyl-, (4S,4'S)- | C25H30N2O2
| | |
| 13 | 868212-93-5 | 1-[4-(3,4-dimethylphenyl)piperazin-1-yl]-3-naphthalen-2-yloxypropan-2-ol | 1-[4-(3,4-dimethylphenyl)piperazin-1-yl]-3-naphthalen-2-yloxypropan-2-ol | C25H30N2O2
| | |
| 14 | 547710-20-3 | N-(4-{4-[(cyclopentylcarbonyl)amino]benzyl}phenyl)cyclopentanecarboxamide | N-(4-{4-[(cyclopentylcarbonyl)amino]benzyl}phenyl)cyclopentanecarboxamide | C25H30N2O2
| | |
| 15 | 1192345-90-6 | (4R,4'R)-2,2'-(戊烷-3,3-二基)双(4-苄基-4,5-二氢噁唑) | (4R,4'R)- 2,2'-(1-ethylpropylidene)bis[4,5-dihydro-4-(phenylmethyl)-Oxazole | C25H30N2O2
| | |
| 16 | | 酪氨酸磷酸化抑制剂SU1498 | (E)-N-(3''-PHENYLPROPYL-ALPHA-CYANO-3'-5'-DIISOPROPYL-4'-HYDROXYCINNAMAMIDE) | C25H30N2O2
| | |
| 17 | 6310-60-7 | 4-[(2,3-dimethoxyphenyl)-(4-dimethylaminophenyl)methyl]-N,N-dimethyl-a niline | 4-[(2,3-dimethoxyphenyl)-(4-dimethylaminophenyl)methyl]-N,N-dimethyl-a niline | C25H30N2O2
| | |
| 18 | 1447917-39-6 | 3-(1-{3-[butyl(methyl)amino]-2-hydroxypropyl}-1H-indol-3-yl)-1-phenyl-2-propen-1-one | 3-(1-{3-[butyl(methyl)amino]-2-hydroxypropyl}-1H-indol-3-yl)-1-phenyl-2-propen-1-one | C25H30N2O2
| | |
| 19 | 1638586-33-0 | ethyl 3-[(3R)-3-{[(1S)-1-phenylethyl]amino}-2,3,4,9-tetrahydro-1H-carbazol-9-yl]propanoate | ethyl 3-[(3R)-3-{[(1S)-1-phenylethyl]amino}-2,3,4,9-tetrahydro-1H-carbazol-9-yl]propanoate | C25H30N2O2
| | |
| 20 | 2621395-77-3 | 6-苄基-2,3,4,5,6,6A-六氢茚并[1,2-B:3,2-B']二吡咯-1(10BH)-羧酸叔丁酯 | tert-Butyl 6-benzyl-2,3,4,5,6,6a-hexahydroindeno[1,2-b:3,2-b']dipyrrole-1(10bH)-carboxylate | C25H30N2O2
| | |
| 21 | 514220-76-9 | 11-(2-sec-butoxyphenyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one | 11-(2-sec-butoxyphenyl)-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one | C25H30N2O2
| | |
| 22 | 296244-59-2 | 1-(8-methyl-1,2,3a,4,5,6-hexahydro-3H-pyrazino[3,2,1-jk]carbazol-3-yl)-3-(2-methylphenoxy)-2-propanol | 1-(8-methyl-1,2,3a,4,5,6-hexahydro-3H-pyrazino[3,2,1-jk]carbazol-3-yl)-3-(2-methylphenoxy)-2-propanol | C25H30N2O2
| | |